Matt Ehrhardt
As a physician–scientist, Dr. Matt Ehrhardt splits his time between caring for young people newly diagnosed with lymphomas and researching the development of survivorship care guidelines for doctors.
- Associate Member, St. Jude Children’s Research Hospital
- Co-Chair, Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult (AYA) Cancers
Dr. Matt Ehrhardt (he/him) is passionate about ensuring survivors of childhood and AYA cancers get the care they need as they enter adulthood and middle age. Data from the St. Jude Lifetime Cohort Study helped his team uncover factors—such as living in an under-resourced area and having a chronic disease—linked to early death in childhood cancer survivors.
Matt also develops and disseminates guidelines, informed by those factors, that can help doctors recommend follow-up care to survivors. “There’s a lot of potential where we could use an aggregate data source to help primary care providers take care of these patients,” he said, adding that linking doctors to electronic health records (EHR) could provide them with past treatment data that would guide care.
CCDI is striving to make that EHR data easier to extract and share, potentially improving care and accelerating research for all children and AYAs with cancer.